Cyclopharma SA Maroc
Cyclopharma SA Maroc is a Moroccan medical technology distributor and subsidiary of T2S Group, specializing in radiopharmaceuticals, contrast media agents, and IVD products, serving hospitals, clinics, and imaging centers across Morocco and francophone Africa.
- Company typePrivate
- Founded1992
- HeadquartersCasablanca, Morocco
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Cyclopharma SA Maroc does
Cyclopharma SA Maroc is the pharmaceutical and radiopharmaceutical distribution subsidiary of T2S Group, a Moroccan MedTech conglomerate founded in 1992 and listed on the Bourse de Casablanca since July 27, 2026. The company distributes iodinated contrast agents (VISIPAQUE, OMNIPAQUE) for CT imaging, gadolinium-based contrast agents (CLARISCAN) for MRI, SPECT radiopharmaceuticals (POLATOM IODOPOL, POLATOM POLTECHNET, POLATOM SODIUM IODIDE, POLATOM KITS, ROTOP KITS), PET radiopharmaceuticals (GLUSCAN, F CHOLINE), and a line of cosmetic dermatology products. The subsidiary sits within T2S Group's four-company structure alongside Techniques Science Santé, IM Alliance, and Binarios, focusing specifically on pharmaceutical and radiopharmaceutical products rather than the broader equipment portfolio carried by sibling subsidiaries. The company is headquartered in Casablanca (Nouaceur) and operates a lean team of 26 employees.
Cyclopharma sells its pharmaceutical and radiopharmaceutical products through a B2B direct sales model targeting hospitals, private clinics, medical laboratories, and imaging centers across Morocco and francophone Africa. Pricing is not publicly disclosed and is handled through direct enterprise engagement, with multi-year contracts and configuration-based quotes. After-sales service and technical support for the distributed products are provided through the parent group's regional infrastructure, including service operations in Nouakchott (Mauritania) and headquarters in Abidjan (Côte d'Ivoire). The company's go-to-market is supplemented by participation in healthcare industry events, including Congrès SMC 2026 (Société Marocaine de Cancérologie) and WHX Dubaï 2026.
Cyclopharma's revenue is generated across five product streams: pharmaceutical products (contrast media and radiopharmaceuticals), medical software solutions (VisionPACS, VisionRIS, VisionHIS, VisionLIS), in vitro diagnostics products (where the group distributes VITROS, VIDAS, BIOFIRE, ARGENE), medical equipment distribution, and after-sales service and maintenance. The company holds distribution partnerships with major international medical technology manufacturers including GE HealthCare, Carl Zeiss Meditec, Bayer Radiology/MEDRAD, MMM Group, ACCURAY, Brainlab, B. Braun, MicroPort, Carestream, bioMérieux, and Hologic. Notable milestones include the installation of the first robotic surgery system in Morocco through the MicroPort Toumai II MedBot partnership.
Cyclopharma SA Maroc firmographics
Firmographics- Name
- Cyclopharma SA Maroc
- Legal name
- Cyclopharma SA Maroc
- Website
- https://t2s.group
- Company type
- Private
- Founded year
- 1992
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Cyclopharma SA Maroc is a Moroccan medical technology distributor and subsidiary of T2S Group, specializing in radiopharmaceuticals, contrast media agents, and IVD products, serving hospitals, clinics, and imaging centers across Morocco and francophone Africa.
- Ownership category
- akta.pro rank
Cyclopharma SA Maroc industry classification
Industry- Product category
- Medical Pharmaceuticals Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421), Biological Product (except Diagnostic) Manufacturing (325414), Medical Equipment and Supplies Manufacturing (3391), In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Surgical & Medical Instruments & Apparatus (3841), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Specialty Pharmacy & Biologics Distribution (CRAOAHAD)
- akta.pro secondary industry
- Medical Supplies & Consumables Wholesale (Non-Device) (CRAOAHAE)
Keywords
Where Cyclopharma SA Maroc is headquartered
LocationHeadquarters
- HQ city
- Casablanca
- HQ country
- Morocco
- HQ region
- Africa
Offices1 record
Markets served
Cyclopharma SA Maroc business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Medical Equipment Distribution: Distribution of medical imaging equipment including MRI systems, CT scanners, X-ray systems, ultrasound machines, mammography, and nuclear medicine equipment from international manufacturers such as GE HealthCare, Carl Zeiss Meditec, and others.
- In Vitro Diagnostics Products: Sale of diagnostic instruments, reagents, and IVD equipment including immunoassay systems (VITROS, VIDAS), molecular biology solutions (BIOFIRE, ARGENE), and microbiology products.
- Pharmaceutical Products: Distribution of contrast media agents, radiopharmaceuticals, and pharmaceutical products for diagnostic and therapeutic applications in healthcare facilities.
- Medical Software Solutions: Sale and distribution of hospital and laboratory information systems (VisionHIS, VisionLIS), radiology information systems (VisionRIS), and picture archiving systems (VisionPACS) with associated maintenance and support services.
- After-Sales Service and Maintenance: Technical support, installation, training, and maintenance services for distributed medical equipment ensuring operational continuity for healthcare providers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | B2B enterprise pricing through direct sales |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels4 records
Cyclopharma SA Maroc product offering
Product offeringCore offering
Cyclopharma SA Maroc, a subsidiary of T2S Group, distributes pharmaceutical products including iodinated and gadolinium-based contrast media agents, SPECT and PET radiopharmaceuticals, and dermatology cosmetic products to healthcare facilities. The company also distributes medical imaging software (VisionPACS, VisionRIS, VisionHIS, VisionLIS), in vitro diagnostics systems, and operates as part of a broader medical technology distribution platform serving hospitals, clinics, and laboratories across Morocco and Africa.
Product overview
Cyclopharma SA Maroc is a subsidiary of T2S Group specializing in pharmaceutical products. The company's portfolio includes iodinated contrast agents (VISIPAQUE) for X-ray and CT imaging, gadolinium-based contrast agents (CLARISCAN) for MRI, SPECT radiopharmaceuticals (POLATOM IODOPOL, POLATOM POLTECHNET, POLATOM SODIUM IODIDE) and radiopharmaceutical kits (POLATOM KITS, ROTOP KITS), PET radiopharmaceuticals (GLUSCAN, F CHOLINE), and cosmetic dermatology products (Derma Instant Youth Cream, Mostal Solution, Photoblock Plus Cream, Sorafine Cremogel, Aquax Cream). The products are distributed through the T2S Group distribution network serving healthcare facilities across Morocco and Africa.
Differentiator
Problem solved
Functional benefit
Brands
- Cyclopharma: A subsidiary of T2S Group specializing in radiopharmaceutical products including contrast products, nuclear medicine products, and pharmaceutical solutions for medical imaging.
Products and services
- VISIPAQUE (Iodinated Contrast Agent)
Quantifiable outcome
- First robotic surgery in Morocco installed by T2S Group
Companies that use Cyclopharma SA Maroc
Customer profileSegments3 records
Ideal customer profiles3 records
Cyclopharma SA Maroc technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Cyclopharma SA Maroc partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core and supporting.
- GE HealthCarecoreStrategic partnership for distribution of comprehensive medical imaging equipment including MRI systems, CT scanners, X-ray machines, ultrasound systems, mammography, nuclear medicine PET/CT systems, and bone densitometry equipment. GE HealthCare is a leading global provider of medical technologies, pharmaceutical diagnostics, and digital solutions.
- Carl Zeiss MediteccoreDistribution partnership for ZEISS ophthalmic laser systems including VISUMAX 800 femtosecond laser, VISULAS YAG III photodisruption laser, VISULAS green photocoagulation laser, and VISULAS combi combined platform. Also distributes surgical microscopes and optical diagnostic equipment.
- Bayer Radiology (MEDRAD)coreDistribution partnership for MEDRAD contrast injection systems including MEDRAD Stellant CT injector, MEDRAD Mark 7 Arterion angiography injector, MEDRAD Salient CT injector, MEDRAD Spectris Solaris EP MRI injector, and MEDRAD MRXperion vascular injector.
- MMM Group (Uniclean)coreDistribution partnership for MMM Group sterilization and decontamination equipment including Uniclean PL II 15 and 30 washer-disinfectors meeting DIN EN ISO 15883 standards for central sterile services departments.
- ACCURAYcorePartnership for CyberKnife S7 robotic radiosurgery system distribution, providing advanced robotic radiation therapy solutions for cancer treatment in Moroccan and African healthcare facilities.
- BrainlabcoreDistribution partnership for Brainlab image-guided surgery and radiosurgery solutions including Curve Navigation, Kick navigation system, Cirq Robotics surgical robot, and Spine & Trauma 3D Navigation systems.
- B. BrauncoreDistribution partnership for B. Braun surgical sutures, meshes, and consumables including Monosyn, Novosyn, Dafilon, Monoplus surgical sutures, Optilène meshes, and other surgical consumables for operating rooms and hospitalization departments.
- MicroPortcorePartnership for Toumai II MedBot surgical robot distribution, enabling first robotic surgery implementation in Morocco and expanding access to minimally invasive surgical capabilities.
- Carestream (Vita Flex CR Systems)supportingDistribution of Carestream computed radiography systems including Vita Flex CR and Classic Directview systems enabling digital transition for hospitals and clinics from film to digital imaging.
- bioMérieux (VIDAS)coreDistribution of bioMérieux VIDAS immunoassay and immunochemistry systems and consumables for clinical laboratory diagnostics including infectious disease testing and biomarker analysis.
- bioMérieux (BIOFIRE FilmArray)coreDistribution partnership for BIOFIRE FilmArray molecular diagnostics systems including FilmArray 2.0 and FilmArray Torch for rapid multiplex PCR testing in clinical microbiology applications.
- Hologic (Mammotome)coreDistribution of Hologic Mammotome breast biopsy systems including Mammotome Revolve for minimally invasive breast biopsy and macrobiopsy procedures.
Scale indicators3 records
Recent moves7 records
Expansion highlights5 records
Cyclopharma SA Maroc competitors and assessment
Company assessmentBroad incumbents
- Siemens Healthineers: Global MedTech OEM and existing Cyclopharma partner. Comparable as a broad incumbent supplying imaging, IVD, and digital health solutions across Africa, sometimes through local distributors and sometimes directly to large hospital systems.
- Philips Healthcare: Global MedTech incumbent with established Africa sales and service operations. Offers overlapping imaging, patient monitoring, and diagnostic solutions to the same hospital and clinic buyers Cyclopharma serves in Morocco and West Africa.
- Fujifilm Healthcare: MedTech OEM offering endoscopy, X-ray, ultrasound, and IVD solutions. Competes with Cyclopharma's portfolio for hospital capex budgets across Morocco and francophone African markets.
- GE HealthCare: Global MedTech OEM and core Cyclopharma partner. Operates broadly across imaging, ultrasound, and pharmaceutical diagnostics in Morocco and Africa, overlapping with Cyclopharma's distribution portfolio and target customers.
- Canon Medical Systems: Imaging-focused MedTech OEM with growing presence in Africa. Directly competes for diagnostic imaging contracts that Cyclopharma services as a distributor, particularly in CT, MRI, and ultrasound.
Direct peers
- bioMérieux: Existing Cyclopharma partner for VIDAS and BIOFIRE systems. Comparable as a direct IVD peer whose products Cyclopharma distributes, with bioMérieux also engaging directly with Moroccan and African labs and hospitals.
- Carl Zeiss Meditec: Existing Cyclopharma partner for ophthalmic lasers and surgical microscopes. A specialty MedTech OEM whose ophthalmology and surgical portfolios overlap directly with Cyclopharma's offering.
- Hologic: Existing Cyclopharma partner for Mammotome breast biopsy systems. A women's-health focused MedTech player whose products Cyclopharma distributes and which also sells directly into larger Moroccan accounts.
- B. Braun: Existing Cyclopharma partner for surgical sutures, meshes, and OR consumables. Comparable as a direct peer in the surgical-supply category across Morocco and West Africa.
Emerging players
- Mindray: Chinese MedTech manufacturer rapidly expanding across Africa in patient monitoring, ultrasound, and IVD. Comparable as an emerging, value-positioned competitor for the same hospital accounts Cyclopharma targets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Cyclopharma SA Maroc social profiles
Digital presenceCyclopharma SA Maroc financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cyclopharma SA Maroc leadership team
Management profileNumber of profiles
Cyclopharma SA Maroc funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cyclopharma SA Maroc M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cyclopharma SA Maroc
What does Cyclopharma SA Maroc do?
Cyclopharma SA Maroc, a subsidiary of T2S Group, distributes pharmaceutical products including iodinated and gadolinium-based contrast media agents, SPECT and PET radiopharmaceuticals, and dermatology cosmetic products to healthcare facilities. The company also distributes medical imaging software (VisionPACS, VisionRIS, VisionHIS, VisionLIS), in vitro diagnostics systems, and operates as part of a broader medical technology distribution platform serving hospitals, clinics, and laboratories across Morocco and Africa.
Is Cyclopharma SA Maroc a public or private company?
Cyclopharma SA Maroc is a private company. It is classified as corporate owned and is currently operating.
When was Cyclopharma SA Maroc founded?
Cyclopharma SA Maroc was founded in 1992. It employs 11 to 50 people.
Where is Cyclopharma SA Maroc based?
Cyclopharma SA Maroc is headquartered in Casablanca, Morocco, in the Africa region.
How does Cyclopharma SA Maroc make money?
Five revenue lines are on record. Medical Equipment Distribution is the primary driver. The others are in Vitro Diagnostics Products, pharmaceutical Products, medical Software Solutions and after-Sales Service and Maintenance.
Who are Cyclopharma SA Maroc's main competitors?
Broad incumbents on record are Siemens Healthineers, Philips Healthcare, Fujifilm Healthcare, GE HealthCare and Canon Medical Systems. Direct peers are bioMérieux, Carl Zeiss Meditec, Hologic and B. Braun. Mindray is listed as an emerging player.
Does Cyclopharma SA Maroc have an API?
No public API is recorded for Cyclopharma SA Maroc.
What industry is Cyclopharma SA Maroc in?
Cyclopharma SA Maroc's product category is Medical Pharmaceuticals Distribution. Its primary akta.pro industry code is CRAOAHAD, Specialty Pharmacy & Biologics Distribution, with a secondary code of CRAOAHAE, Medical Supplies & Consumables Wholesale (Non-Device). Its NAICS code is 42421 and its SIC code is 2836.